The aml Hub website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and the aml Hub cannot guarantee the accuracy of translated content. The aml and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.
The AML Hub is an independent medical education platform, sponsored by Astellas, Daiichi Sankyo, Johnson & Johnson, Kura Oncology and Syndax, and has been supported through educational grants from Bristol Myers Squibb and the Hippocrate Conference Institute, an association of the Servier Group. The funders are allowed no direct influence on our content. The levels of sponsorship listed are reflective of the amount of funding given. View funders.
Now you can support HCPs in making informed decisions for their patients
Your contribution helps us continuously deliver expertly curated content to HCPs worldwide. You will also have the opportunity to make a content suggestion for consideration and receive updates on the impact contributions are making to our content.
Find out more
Create an account and access these new features:
Bookmark content to read later
Select your specific areas of interest
View aml content recommended for you
What are the differences and similarities between transplant practices in North America and Europe?
Featured:
During the 46th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), the AML Hub spoke to Robert Soiffer, Dana-Farber Cancer Institute, Boston, US, about blood and bone marrow transplant. We asked, What are the differences and similarities between transplant practices in North America and Europe?
What are the differences and similarities between transplant practices in North America and Europe?
While acknowledging that transplant practice is similar overall between the two regions, Robert Soiffer identified a few key differences in relation to the age of transplant patient, the use of high-intensity conditioning regimens, the approach to graft-versus-host disease prophylaxis, and the use of in vivo T-cell depletion.